323 related articles for article (PubMed ID: 33030251)
21. Interleukin-7 enhances anti-tumor activity of CD8
Teng D; Ding L; Cai B; Luo Q; Wang H
Cytokine; 2019 Jun; 118():115-123. PubMed ID: 29655570
[TBL] [Abstract][Full Text] [Related]
22. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Zhang M; Zhao H; Gao H
Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinoma.
Li Q; Bao JM; Li XL; Zhang T; Shen XH
Chin Med J (Engl); 2012 Mar; 125(5):786-93. PubMed ID: 22490576
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.
Shi J; Wang Y; Wang F; Zhu Z; Gao Y; Zhang Q; Du Z
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):855-864. PubMed ID: 32205116
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
27. Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment.
Macek Jilkova Z; Aspord C; Kurma K; Granon A; Sengel C; Sturm N; Marche PN; Decaens T
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00058. PubMed ID: 31295151
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma.
Liu S; Yang L; Jia S; Zhao R; Jin Z
Int Immunopharmacol; 2021 Nov; 100():108161. PubMed ID: 34555643
[TBL] [Abstract][Full Text] [Related]
29. LAIR1-mediated resistance of hepatocellular carcinoma cells to T cells through a GSK-3β/β-catenin/MYC/PD-L1 pathway.
Pan B; Ke X; Qiu J; Ye D; Zhang Z; Zhang X; Luo Y; Yao Y; Wu X; Wang X; Tang N
Cell Signal; 2024 Mar; 115():111039. PubMed ID: 38199599
[TBL] [Abstract][Full Text] [Related]
30. PD-1 expression is elevated in monocytes from hepatocellular carcinoma patients and contributes to CD8 T cell suppression.
Yun J; Yu G; Hu P; Chao Y; Li X; Chen X; Wei Q; Wang J
Immunol Res; 2020 Dec; 68(6):436-444. PubMed ID: 32975728
[TBL] [Abstract][Full Text] [Related]
31. IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4
Jin Z; Lei L; Lin D; Liu Y; Song Y; Gong H; Zhu Y; Mei Y; Hu B; Wu Y; Zhang G; Liu H
J Immunol; 2018 Dec; 201(12):3770-3779. PubMed ID: 30446569
[TBL] [Abstract][Full Text] [Related]
32. Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment.
Wang W; Wu J; Ji M; Wu C
J Transl Med; 2020 Dec; 18(1):477. PubMed ID: 33308251
[TBL] [Abstract][Full Text] [Related]
33. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
34. Levels of chemokine receptors expressed on peripheral blood T lymphocytes of Egyptian patients with hepatocellular carcinoma.
Allam MM; Abd El Moneim E; Hassouna MM; El Jaky A; Zaghlah H
Egypt J Immunol; 2009; 16(1):17-25. PubMed ID: 20726319
[TBL] [Abstract][Full Text] [Related]
35. NCR
Liu Y; Song Y; Lin D; Lei L; Mei Y; Jin Z; Gong H; Zhu Y; Hu B; Zhang Y; Zhao L; Teo HY; Qiu J; Jiang W; Dong C; Wu D; Huang Y; Liu H
EBioMedicine; 2019 Mar; 41():333-344. PubMed ID: 30827928
[TBL] [Abstract][Full Text] [Related]
36. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
[TBL] [Abstract][Full Text] [Related]
37. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
Zhang Q; Yang L; Liu S; Zhang M; Jin Z
Front Immunol; 2021; 12():645835. PubMed ID: 34177894
[TBL] [Abstract][Full Text] [Related]
39. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
Yang C; Qian Q; Zhao Y; Huang B; Chen R; Gong Q; Ji H; Wang C; Xia L; You Z; Zhang J; Chen X
Front Immunol; 2023; 14():1112672. PubMed ID: 36993960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
